These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4397820)

  • 1. The serum concentration of bactericidal antibiotics (rifampicin, cephaloridine) in relation to the low resistance period in experimental infections. Immunological investigations in experimental chemotherapy. V.
    Sackmann W
    Chemotherapy; 1971; 16(3):203-10. PubMed ID: 4397820
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the low resistance period in determining the effective dosage of chlortetracycline in mice. Immunological investigations in experimental chemotherapy. IV.
    Sackmann W
    Chemotherapy; 1971; 16(3):196-202. PubMed ID: 4397819
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological investigations in experimental chemotherapy. 3. The initial period of low resistance in bacterial infections of mice in relation to bacteriostatic chemotherapy.
    Sackmann W
    Chemotherapia (Basel); 1968; 13(5):276-88. PubMed ID: 4889161
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dosage and method of action of bactericidal drugs in relation to the "low resistance period" in animal experiment].
    Sackmann W
    Pathol Microbiol (Basel); 1970; 36(5):284. PubMed ID: 4935368
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological investigations in experimental chemotherapy. II. Resistance to re-infection, its specificity and dependence upon the inoculum.
    Sackmann W
    Chemotherapy; 1966; 11(2):95-103. PubMed ID: 4380958
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological investigations in experimental chemotherapy. I. The susceptibility of mice to homologous re-infection following antibacterial treatment.
    Sackmann W
    Chemotherapy; 1966; 11(2):86-94. PubMed ID: 4380957
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
    Shorin VA; Shapovalova SP; Malkova IV
    Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological studies of experimental chemotherapy. IV. The significance of resistance to infection for the dosage of chlortetracycline in the mouse].
    Sackmann W
    Pathol Microbiol (Basel); 1969; 34(3):155-7. PubMed ID: 4392347
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of cephaloridine.
    Steigbigel NH; Kislak JW; Tilles JG; Finland M
    Arch Intern Med; 1968 Jan; 121(1):24-38. PubMed ID: 5635071
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV].
    Shorin VA; Shapovalova SP
    Antibiotiki; 1974 Jan; 19(1):3-6. PubMed ID: 4156904
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampicin: a new rifamycin. I. Bacteriological studies.
    Arioli V; Pallanza R; Furesz S; Carniti G
    Arzneimittelforschung; 1967 May; 17(5):523-9. PubMed ID: 4385644
    [No Abstract]   [Full Text] [Related]  

  • 12. [Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
    Gauze GF; Brazhnikova MG; Shorin VA; Maksimova TS; Ol'khovatova OL; Kudinova MK; Vishniakova IA; Pevzner NS; Shapovalova SP
    Antibiotiki; 1970 Jun; 15(6):483-6. PubMed ID: 4394064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microbiological evaluation of a new synthetic cephalosporin, cephapirin (author's transl)].
    Nakazawa S; Otsuki M; Kida K; Sakamichi T; Tanaka S
    Jpn J Antibiot; 1974 Apr; 27(2):164-73. PubMed ID: 4152697
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fundamental studies on synthetic cephalosporin antibiotics. 2. Therapeutic effects of oral administration on experimental infections in mice and their distribution in the body].
    Nakazawa S; Tsuji A; Watanaba Y; Tsujimoto S
    J Antibiot B; 1967 Aug; 20(4):254-8. PubMed ID: 4866093
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bacteriological and pharmacological properties of new cephalosperine antibiotics. II. Cephaloridine].
    Naumann P
    Arzneimittelforschung; 1967 Apr; 17(4):469-81. PubMed ID: 4386771
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: New antibacterial agent via photofluorination of a bacterial cell wall constituent.
    Kollonitsch J; Barash L; Kahan FM; Kropp H
    Nature; 1973 Jun; 243(5406):346-7. PubMed ID: 4147634
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of sulfasymazine in infections in mice.
    Redin GS; McCoy ME
    Chemotherapy; 1966; 11(6):309-14. PubMed ID: 5338947
    [No Abstract]   [Full Text] [Related]  

  • 19. Cephaloridine: clinical and laboratory studies in children.
    Azimi PH; Cramblett HG
    J Pediatr; 1968 Aug; 73(2):255-61. PubMed ID: 4875772
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacteriological studies on cefatrizine (S-640 P) (author's transl)].
    Matsuzaki M; Tado N; Hirata Y; Kato M; Nakumura K
    Jpn J Antibiot; 1976 Jan; 29(1):61-8. PubMed ID: 4635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.